Paper Title

Risk of complications associated with febrile neutropenia among patients undergoing chemotherapy using MASCC risk index.

Article Identifiers

Registration ID: IJNRD_194478

Published ID: IJNRDTH00069

DOI: Click Here to Get

Authors

Sini.K .Oommen

Keywords

Febrile neutropenia ; Multinational Association of Supportive Care in Cancer (MASCC) risk index ; Chemotherapy

Abstract

A descriptive study was done to assess the risk of complications associated with febrile neutropenia among patients undergoing chemotherapy using MASCC risk index in a selected hospital, Pathnamthitta. The objectives of the study were to assess the risk of complications associated with febrile neutropenia among patients undergoing chemotherapy and to find out the association between the risk of complications associated with febrile neutropenia and the selected baseline variables of the patients undergoing chemotherapy. Descriptive research design was used for the present study. Health promotion model by Nola. J. Pender was used as the conceptual framework for the study. The study was done among 30 patients. The samples were selected using non probability purposive sampling technique. Baseline data assessment proforma and MASCC risk index score were used as the tools for data collection. Descriptive and inferential statistics were used for data analysis. The study identified 56.7% of the samples as high risk group and 43.3% as low risk group. Significant association was found between the MASCC risk index score with type of cancer and history of prior stem cells or bone marrow transplantation. The study concluded that majority of the samples were belong to high risk. This shows patients undergoing chemotherapy have a greater risk for developing complications associated with febrile neutropenia and prompt monitoring is required. MASCC risk index is a reliable tool for assessing the risk of complications among chemotherapy patients.

How To Cite (APA)

Sini.K .Oommen (August-2023). Risk of complications associated with febrile neutropenia among patients undergoing chemotherapy using MASCC risk index.. INTERNATIONAL JOURNAL OF NOVEL RESEARCH AND DEVELOPMENT, 8(8), 464-525. https://ijnrd.org/papers/IJNRDTH00069.pdf

Issue

Volume 8 Issue 8, August-2023

Pages : 464-525

Other Publication Details

Paper Reg. ID: IJNRD_194478

Published Paper Id: IJNRDTH00069

Downloads: 000121989

Research Area: Health Science 

Country: Pathanamthitta, Kerala, India

Published Paper PDF: https://ijnrd.org/papers/IJNRDTH00069.pdf

Published Paper URL: https://ijnrd.org/viewpaperforall?paper=IJNRDTH00069

About Publisher

Journal Name: INTERNATIONAL JOURNAL OF NOVEL RESEARCH AND DEVELOPMENT(IJNRD)

ISSN: 2456-4184 | IMPACT FACTOR: 8.76 Calculated By Google Scholar | ESTD YEAR: 2016

An International Scholarly Open Access Journal, Peer-Reviewed, Refereed Journal Impact Factor 8.76 Calculate by Google Scholar and Semantic Scholar | AI-Powered Research Tool, Multidisciplinary, Monthly, Multilanguage Journal Indexing in All Major Database & Metadata, Citation Generator

Publisher: IJNRD (IJ Publication) Janvi Wave | IJNRD.ORG | IJNRD.COM | IJPUB.ORG

Publication Timeline

Peer Review
Through Scholar9.com Platform

Article Preview: View Full Paper

Call For Paper

Call For Paper - Volume 10 | Issue 10 | October 2025

IJNRD is a Scholarly Open Access, Peer-reviewed, and Refereed Journal with a High Impact Factor of 8.76 (calculated by Google Scholar & Semantic Scholar | AI-Powered Research Tool). It is a Multidisciplinary, Monthly, Low-Cost Journal that follows UGC CARE 2025 Peer-Reviewed Journal Policy norms, Scopus journal standards, and Transparent Peer Review practices to ensure quality and credibility. IJNRD provides indexing in all major databases & metadata repositories, a citation generator, and Digital Object Identifier (DOI) for every published article with full open-access visibility.

The INTERNATIONAL JOURNAL OF NOVEL RESEARCH AND DEVELOPMENT (IJNRD) aims to advance applied, theoretical, and experimental research across diverse fields. Its goal is to promote global scientific information exchange among researchers, developers, engineers, academicians, and practitioners. IJNRD serves as a platform where educators and professionals can share research evidence, models of best practice, and innovative ideas, contributing to academic growth and industry relevance.

Indexing Coverage includes Google Scholar, SSRN, ResearcherID-Publons, Semantic Scholar (AI-Powered Research Tool), Microsoft Academic, Academia.edu, arXiv.org, ResearchGate, CiteSeerX, ResearcherID (Thomson Reuters), Mendeley, DocStoc, ISSUU, Scribd, and many more recognized academic repositories.

How to submit the paper?

Important Dates for Current issue

Paper Submission Open For: October 2025

Current Issue: Volume 10 | Issue 10 | October 2025

Impact Factor: 8.76

Last Date for Paper Submission: Till 31-Oct-2025

Notification of Review Result: Within 1-2 Days after Submitting paper.

Publication of Paper: Within 01-02 Days after Submititng documents.

Frequency: Monthly (12 issue Annually).

Journal Type: IJNRD is an International Peer-reviewed, Refereed, and Open Access Journal with Transparent Peer Review as per the new UGC CARE 2025 guidelines, offering low-cost multidisciplinary publication with Crossref DOI and global indexing.

Subject Category: Research Area

Call for Paper: More Details